Sfoglia per Autore
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
2015 Clausi, V; Giannecchini, S; Magnani, E; Repice, A; Mechi, C; Martelli, F; Azzi, A; Massacesi, L.
Leptomeningeal enhancement analysis in diagnostic clinical setting
2015 Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases.
2016 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L.
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments
2017 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.
2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis.
2017 M., Grammatico; Dallagiacoma, S.; Lorenzoni, L.; Carlucci, G.; Repice, A. M.; Mechi, C.; Magnani, E.; Vuolo, L.; Fainardi, E.; Massacesi, L.
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports
2017 Mariottini, A; Forci, B; Magnani, E; Massacesi, L; Repice, A
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination
2018 Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis.
2019 Mariottini A, Innocenti C, Forci B, Magnani E, Mechi C, Barilaro A, Nistri R, Fani A, Saccardi R, Massacesi L, Repice AM.
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation
2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
Association of celiac disease in patients with multiple sclerosis in Tuscany
2020 Piccini, Barbara; Ulivelli, Monica; Amato, Maria Pia; Bartalini, Sabina; Falcini, Mario; Giannini, Marta; Magnani, Eliana; Massacesi, Luca; Repice, Anna Maria; Vascotto, Marina; Grosso, Salvatore
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile